Blood Based Biomarkers of Central Nervous System Involvement in Wilson’s Disease

Wilson’s Disease—Genetic Puzzles with Diagnostic Implications

(2023) Grażyna Gromadzka et al.   Diagnostics

Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations

(2022) Tjalf Ziemssen et al.   MOVEMENT DISORDERS

Serum Neurofilament Light Chain in Wilson's Disease: A Promising Indicator but Unparallel to Real‐Time Treatment Response

(2022) Rou‐Min Wang et al.   MOVEMENT DISORDERS

Brain magnetic resonance imaging and severity of neurological disease in Wilson’s disease — the neuroradiological correlations

(2022) Barbara Rędzia-Ogrodnik et al.   NEUROLOGICAL SCIENCES

NfL as Analogue of C-Reactive Protein in Neurologic Diseases

(2022) Lorenzo Gaetani et al.   NEUROLOGY

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease

(2022) Tjalf Ziemssen et al.   ACTA NEUROLOGICA BELGICA

Higher Concentration of Plasma Glial Fibrillary Acidic Protein in Wilson Disease Patients With Neurological Manifestations

(2021) Jie Lin et al.   MOVEMENT DISORDERS

Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients

(2021) Rebecca De Lorenzo et al.   JOURNAL OF NEUROLOGY

Wilson’s disease: update on pathogenesis, biomarkers and treatments

(2021) Samuel Shribman et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Plasma neurofilament light chain as a biomarker in Wilson's disease

(2021) Jie Yang et al.   PARKINSONISM & RELATED DISORDERS

Neurofilaments: The C-Reactive Protein of Neurology

(2020) Kate L. Lambertsen et al.   Brain Sciences

Semiquantitative Scale for Assessing Brain MRI Abnormalities in Wilson Disease: A Validation Study

(2020) Petr Dusek et al.   MOVEMENT DISORDERS

Liver transplantation as a rescue therapy for severe neurologic forms of Wilson disease

(2020) Aurélia Poujois et al.   NEUROLOGY

Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease

(2020) Samuel Shribman et al.   MOVEMENT DISORDERS

Brain volume is related to neurological impairment and to copper overload in Wilson’s disease

(2019) Lukasz Smolinski et al.   NEUROLOGICAL SCIENCES

Wilson disease—treatment perspectives

(2019) Tomasz Litwin et al.   Annals of Translational Medicine

Tau filaments in neurodegenerative diseases

(2018) Michel Goedert   FEBS LETTERS

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Wilson disease

(2018) Anna Członkowska et al.   Nature Reviews Disease Primers

Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau

(2017) Keith A. Josephs   MAYO CLINIC PROCEEDINGS

Exchangeable copper: a reflection of the neurological severity in Wilson's disease

(2016) A. Poujois et al.   EUROPEAN JOURNAL OF NEUROLOGY

Early neurological worsening in patients with Wilson's disease

(2015) Tomasz Litwin et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

(2015) C.-H. Lu et al.   NEUROLOGY

EASL Clinical Practice Guidelines: Wilson’s disease

(2015)   JOURNAL OF HEPATOLOGY

Long-term Outcome for Wilson Disease: 85% Good

(2013) Michael L. Schilsky   Clinical Gastroenterology and Hepatology

Long-term Outcomes of Patients With Wilson Disease in a Large Austrian Cohort

(2013) Sandra Beinhardt et al.   Clinical Gastroenterology and Hepatology

Long term results of liver transplantation for Wilson’s disease: Experience in France

(2013) Olivier Guillaud et al.   JOURNAL OF HEPATOLOGY

Long-term follow-up of Wilson Disease: natural history, treatment, mutations analysis and phenotypic correlation

(2010) Radan Bruha et al.   LIVER INTERNATIONAL

What are biomarkers?

(2010) Kyle Strimbu et al.   Current Opinion in HIV and AIDS

A novel Global Assessment Scale for Wilson's Disease (GAS for WD)

(2009) Annu Aggarwal et al.   MOVEMENT DISORDERS